Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

CNCE

Concert Pharmaceuticals (CNCE)

Concert Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CNCE
FechaHoraFuenteTítuloSímboloCompañía
02/05/201705:30Business WireConcert Pharmaceuticals Initiates CTP-543 Phase 2 Trial in Alopecia AreataNASDAQ:CNCEConcert Pharmaceuticals Inc
26/04/201716:23Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CNCEConcert Pharmaceuticals Inc
25/04/201706:00Business WireConcert Pharmaceuticals to Report First Quarter 2017 Financial Results on May 2, 2017, & Present at Upcoming Investor Confere...NASDAQ:CNCEConcert Pharmaceuticals Inc
10/04/201715:30Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CNCEConcert Pharmaceuticals Inc
05/04/201707:18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNCEConcert Pharmaceuticals Inc
23/03/201716:28Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:CNCEConcert Pharmaceuticals Inc
16/03/201715:02Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CNCEConcert Pharmaceuticals Inc
13/03/201715:15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
13/03/201715:15Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
09/03/201709:47Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/201706:30Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/201706:29Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/201706:15Business WireConcert Pharmaceuticals Reports Year Ended 2016 Financial ResultsNASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/201706:00Business WireVertex to Acquire CTP-656 from Concert Pharmaceuticals for the Treatment of Cystic FibrosisNASDAQ:CNCEConcert Pharmaceuticals Inc
04/03/201709:00Business WireConcert Pharmaceuticals Presents CTP-543 Phase 1 Results at American Academy of Dermatology Annual MeetingNASDAQ:CNCEConcert Pharmaceuticals Inc
02/03/201706:00Business WireConcert Pharmaceuticals to Report Full Year 2016 Results on March 6, 2017, and Present at Upcoming Investor ConferencesNASDAQ:CNCEConcert Pharmaceuticals Inc
20/01/201707:30Business WireConcert Pharmaceuticals Receives FDA Orphan Drug Designation for CTP-656 for the Treatment of Cystic FibrosisNASDAQ:CNCEConcert Pharmaceuticals Inc
17/01/201706:00Business WireConcert Pharmaceuticals Provides Further Details on CTP-656 Development in U.S. and EuropeNASDAQ:CNCEConcert Pharmaceuticals Inc
21/12/201606:30Business WireConcert Pharmaceuticals Initiates Phase 2 Clinical Trial Evaluating CTP-656 for the Treatment of Cystic FibrosisNASDAQ:CNCEConcert Pharmaceuticals Inc
14/12/201606:30Business WireConcert Pharmaceuticals Announces CTP-543 Positive Top-Line Phase 1 ResultsNASDAQ:CNCEConcert Pharmaceuticals Inc
07/12/201615:12Edgar (US Regulatory)Amended Annual Statement of Changes in Beneficial Ownership (5/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
08/11/201606:38Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CNCEConcert Pharmaceuticals Inc
08/11/201606:00Business WireConcert Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Company UpdateNASDAQ:CNCEConcert Pharmaceuticals Inc
01/11/201606:00Business WireConcert Pharmaceuticals to Report Third Quarter 2016 Financial Results on November 8, 2016, & Present at Upcoming Investor Co...NASDAQ:CNCEConcert Pharmaceuticals Inc
27/10/201610:15Business WireConcert Pharmaceuticals Presents Poster at 2016 North American Cystic Fibrosis ConferenceNASDAQ:CNCEConcert Pharmaceuticals Inc
24/10/201609:00GlobeNewswire Inc.Concert Pharmaceuticals, Inc. (Nasdaq: CNCE) to Ring The Nasdaq Stock Market Closing BellNASDAQ:CNCEConcert Pharmaceuticals Inc
21/09/201615:01Business WireConcert Pharmaceuticals Announces Upcoming Poster Presentation at North American Cystic Fibrosis ConferenceNASDAQ:CNCEConcert Pharmaceuticals Inc
06/09/201606:00Business WireConcert Pharmaceuticals Expands Management TeamNASDAQ:CNCEConcert Pharmaceuticals Inc
01/09/201606:00Business WireConcert Pharmaceuticals to Present at Upcoming Investor ConferencesNASDAQ:CNCEConcert Pharmaceuticals Inc
09/08/201606:00Business WireConcert Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Company UpdateNASDAQ:CNCEConcert Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CNCE

Su Consulta Reciente

Delayed Upgrade Clock